Transgenic animal models for type 1 diabetes: Linking a tetracycline-inducible promoter with a virus-inducible mouse model

Transgenic Research

Volumn 11, Issue 6, 2002, Pages 587-595

  Christen, Urs ^a   Von Herrath, Matthias G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Autoimmunity; Chemokine; Cytokine; Doxycycline; Virus infection

Indexed keywords

ANIMALIA;

TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; PROMOTER REGION; REVIEW; TRANSGENIC MOUSE; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); TETRACYCLINE; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 0142213142     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021144209209     Document Type: Review

References (30)

1. Baron U and Bujard H (2000) Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Meth Enzymol 327: 401-421.
2. Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W and Bujard H (1999) Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci USA 96: 1010-1018.
3. Christen U and von Herrath MG (2002) Cytokines and chemokines in virus-induced autoimmunity. In: Santamaria P (ed.), Cytokines in Autoimmune Disease. Landes Biosience, Austin, TX (in press).
4. Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA et al. (2001) A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166: 7023-7032.
5. Cope AP, Liblau RS, Yang XD, Congia M, Laudanna C, Schreiber RD et al. (1997) Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185: 1573-1584.
6. Freundlieb S, Schirra-Muller C and Bujard H (1999) A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1: 4-12.
7. Furth PA, St Onge L, Boeger H, Gruss P, Gossen M, Kistner A et al. (1994) Temporal control of gene expression in transgenic mice by a tetracycline-responsive promotor. Proc Natl Acad Sci USA 91: 9302-9306.
8. Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promotors. Proc Natl Acad Sci USA 89: 5547-5551.
9. Gossen M, Freundlieb S, Bender G, Mueller G, Hillen W and Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
10. Green EA, Eynon EE and Flavell RA (1998) Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9: 733-743.
11. Green EA and Flavell RA (1999) Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol Rev 169: 11-22.
12. Green EA and Flavell RA (2000) The temporal importance of TNFalpha expression in the development of diabetes. Immunity 12: 459-469.
13. Green EA, Wong FS, Eshima K, Mora C and Flavell RA (2000) Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. J Exp Med 191: 225-238.
14. Grewal IS, Grewal KD, Wong S, Picarella DE, Janeway CA and Flavell RA (1996) Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J Exp Med 184: 1963-1974.
15. Guerder S, Picarella DE, Linsley PS and Flavell RA (1994) Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 91: 5138-5142.
16. Jacob CO, Aiso S, Michie SA, McDevitt HO and Acha-Orbea H (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA 87: 968-972.
17. Jacob CO, Aiso S, Schreiber RD and McDevitt HO (1992) Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development. Int Immunol 4: 611-614.
18. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Luebbert H et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93: 10933-10938.
19. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, Eugui EM et al. (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 85: 1204-1208.
20. Mayo KE, Warren R and Palmiter RD (1982) The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 29: 99-108.
21. Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B et al. (1991) Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317.
22. Oldstone MBA, Nerenberg M, Southern P, Price J and Lewicki H (1991) Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319-331.
23. Picarella DE, Kratz A, Li C, Ruddle N and Flavell RA (1993) Transgenic tumour necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. J Immunol 150: 4136-4150.
24. Trembley P, Meiner Z, Galou M, Heinrich C, Petromilli C, Lisse T et al. (1998) Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci USA 95: 12580-12585.
25. von Herrath MG, Dockter J and Oldstone MBA (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1: 231-242.
26. von Herrath MG and Holz A (1997) Pathological changes in the islet miliue precede infiltration of islets and destruction of β-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J Autoimmun 10: 231-238.
27. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman Jr. HA et al. (2000) Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192: 1587-6000.
28. Witzgall R, O'Leary E, Leaf A, Onaldi D and Bonventre JV (1994) The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci USA 91: 4514-1518.
29. Yang X-D, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD et al. (1994) Effect of tumour necrosis factor α on insulin-dependent diabetes mellitus in NOD mice: I. the early development of autoimmunity and the diabetogenic process. J Exp Med 180: 995-1004.
30. Zhu Z, Ma B, Homer RJ, Zheng T and Elias JA (2001) Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 276: 25222-25229.